Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Familial Combined Hyperlipidemia”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Not applicableStudy completedNCT00005313
What this trial is testing

Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia

Who this might be right for
AtherosclerosisCardiovascular DiseasesHeart Diseases+2 more
University of Washington 450
Large-scale testing (Phase 3)Not Yet RecruitingNCT07421284
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy

Who this might be right for
Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 900
Testing effectiveness (Phase 2)Study completedNCT01279590
What this trial is testing

Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)

Who this might be right for
MyalgiaHypercholesterolemiaHyperlipidemia
Furiex Pharmaceuticals, Inc 282
Testing effectiveness (Phase 2)Looking for participantsNCT07223658
What this trial is testing

Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia

Who this might be right for
Hyperlipidemia; Mixed
Arrowhead Pharmaceuticals 78
Large-scale testing (Phase 3)Study completedNCT05255458
What this trial is testing

Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Akeso 122
Large-scale testing (Phase 3)UnknownNCT01956201
What this trial is testing

Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin

Who this might be right for
Mixed Hyperlipidemia
Chong Kun Dang Pharmaceutical 476
Post-approval studies (Phase 4)Study completedNCT00473655
What this trial is testing

Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients

Who this might be right for
HypertriglyceridemiaHyperlipoproteinemia Type IVHyperlipoproteinemia Type V+2 more
AstraZeneca 334
Large-scale testing (Phase 3)Study completedNCT00093899
What this trial is testing

Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

Who this might be right for
HyperlipidemiaHypercholesterolemiaHypertriglyceridemia
Organon and Co 611
Post-approval studies (Phase 4)Study completedNCT00637078
What this trial is testing

STITCH2 (Simplified Therapeutic Intervention to Control Hypertension and Hypercholesterolemia)

Who this might be right for
HypertensionHypercholesterolemia
University of Western Ontario, Canada 1,000
Large-scale testing (Phase 3)Ended earlyNCT00145431
What this trial is testing

Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.

Who this might be right for
Hyperlipoproteinemia Type III
Pfizer 41
Testing effectiveness (Phase 2)Study completedNCT02008084
What this trial is testing

A Pilot Study to Evaluate the Lipid Effects of TRIA-662

Who this might be right for
HypertriglyceridemiaMixed Hyperlipidemia
Cortria Corporation 71
Large-scale testing (Phase 3)Study completedNCT00378833
What this trial is testing

Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054)

Who this might be right for
HypercholesterolemiaHyperlipidemia
Merck Sharp & Dohme LLC 1,300
Large-scale testing (Phase 3)Not Yet RecruitingNCT07441317
What this trial is testing

QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Qilu Pharmaceutical Co., Ltd. 780
Large-scale testing (Phase 3)Study completedNCT00552097
What this trial is testing

Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)

Who this might be right for
AtherosclerosisHypercholesterolemiaHyperlipoproteinemia Type II
Organon and Co 720
Not applicableStudy completedNCT01476436
What this trial is testing

Low Carbohydrate Diet - Effect on Plasma Lipids and Metabolic Markers

Who this might be right for
Overweight and ObesityType IIb HyperlipidaemiaHypercholesterolemia Aggravated
Oslo University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00941603
What this trial is testing

Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipidemia
Merck Sharp & Dohme LLC 619
Testing effectiveness (Phase 2)Study completedNCT01594983
What this trial is testing

A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia

Who this might be right for
Non Familial Chylocmicronemia Syndrome (Non-FCS)
Novartis Pharmaceuticals 58
Large-scale testing (Phase 3)Study completedNCT03337308
What this trial is testing

A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy

Who this might be right for
Hyperlipidemias
Esperion Therapeutics, Inc. 382
Post-approval studies (Phase 4)Study completedNCT00345657
What this trial is testing

Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care

Who this might be right for
HyperlipidemiaMixed HyperlipidemiaDyslipidemia
In His Image 100
Testing effectiveness (Phase 2)Study completedNCT07421232
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 156
Load More Results